79 related articles for article (PubMed ID: 3131152)
1. Effect of 1.25 (OH)2 vitamin D3 (calcitriol) on TRH-induced thyrotropin secretion in man.
Zofková I; Bednár J
Exp Clin Endocrinol; 1988 Mar; 91(1):7-12. PubMed ID: 3131152
[TBL] [Abstract][Full Text] [Related]
2. Trifluoperazine inhibits thyrotropin-releasing hormone-stimulated TSH secretion.
Zofková I; BednárJ
Horm Metab Res; 1986 Sep; 18(9):621-4. PubMed ID: 3096861
[TBL] [Abstract][Full Text] [Related]
3. Effects of calcitonin, 1,25(OH)2 vitamin D3 and trifluoperazine on thyrotropic secretion and their mutual interactions.
Zofková I; Bednár J
Exp Clin Endocrinol; 1988 Mar; 92(3):268-74. PubMed ID: 3150956
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin inhibits TRH-induced TSH secretion.
Zofková I; Bednár J
Exp Clin Endocrinol; 1984 May; 83(3):263-8. PubMed ID: 6432564
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1,25-dihydroxyvitamin D3 (calcitriol) on prolactin secretion at rest and TRH-stimulated secretion in humans.
Zofková I; Nedvídková J
Exp Clin Endocrinol; 1988 May; 91(2):207-11. PubMed ID: 3137083
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells.
D'Emden MC; Wark JD
Endocrinology; 1987 Sep; 121(3):1192-4. PubMed ID: 3113918
[TBL] [Abstract][Full Text] [Related]
9. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of 100 micrograms TRH intravenously and 40 mg TRH orally in euthyroidism (author's transl)].
Passath A; Stradner F; Petritsch W; Goebel ; Leb G
Acta Med Austriaca; 1981; 8(3):75-81. PubMed ID: 6791450
[TBL] [Abstract][Full Text] [Related]
11. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
Coiro V; Vescovi PP
Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH.
Coiro V; Volpi R; Cataldo S; Capretti L; Caffarri G; Pilla S; Chiodera P
J Investig Med; 2000 Mar; 48(2):133-6. PubMed ID: 10736973
[TBL] [Abstract][Full Text] [Related]
13. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
14. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response.
Winokur A; Caroff SN; Amsterdam JD; Maislin G
Biol Psychiatry; 1984 May; 19(5):695-702. PubMed ID: 6428472
[TBL] [Abstract][Full Text] [Related]
15. Influence of the interaction of calcitonin and 1,25(OH)2-vitamin D3 on prolactin secretion.
Zofková I; Nedvídková J
Exp Clin Endocrinol; 1988 Mar; 92(3):262-7. PubMed ID: 2855317
[TBL] [Abstract][Full Text] [Related]
16. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
Foley TP; Owings J; Hayford JT; Blizzard RM
J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
[TBL] [Abstract][Full Text] [Related]
17. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
Maturlo SJ; Rosenbaum RL; Pan C; Surks MI
J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
[TBL] [Abstract][Full Text] [Related]
18. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
Snyder PJ; Utiger RD
J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
[TBL] [Abstract][Full Text] [Related]
19. The thyrotropin releasing hormone stimulation test in alcoholism.
Pienaar WP; Roberts MC; Emsley RA; Aalbers C; Taljaard FJ
Alcohol Alcohol; 1995 Sep; 30(5):661-7. PubMed ID: 8554651
[TBL] [Abstract][Full Text] [Related]
20. Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism.
Szilágyi G; Szabolcs I; Vydra G; Góth M; Irsy G
Acta Med Hung; 1984; 41(4):175-83. PubMed ID: 6440114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
